全球猪血浆饲料市场 – 行业趋势及 2031 年预测

猪血浆饲料市场分析及规模

在蓬勃发展的猪血浆饲料市场中，猪血浆粉的使用标志着一项重大进步。这种营养丰富的成分可增强动物的健康和生长，确保猪生产的最佳性能。将其加入饲料配方中可带来切实的好处，例如提高消化率、免疫支持和整体生长效率，凸显其在现代牲畜营养中不可或缺的作用。

2023 年全球猪血浆饲料市场规模价值 12.2 亿美元，预计到 2031 年将达到 18.8 亿美元，2024 年至 2031 年预测期内的复合年增长率为 5.50%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

报告范围和市场细分       

市场定义

Porcine plasma feed is a nutritional supplement derived from the blood of pigs. It is rich in proteins, amino acids, and other essential nutrients crucial for animal growth and health. Added to livestock diets, it enhances growth performance, immune function, and overall health. Its bioavailability and digestibility make it a valuable component in animal nutrition, particularly for young or stressed animals.

Porcine Plasma Feed Market Dynamics

Drivers

• Increased Demand For High Quality Pet Food

The growing demand for premium pet nutrition is propelling growth in the market, particularly in the incorporation of animal-derived spray dried porcine plasma into canned pet food. Its rich protein content and favorable physicochemical properties make it a preferred ingredient. This increased acceptance is driving demand for higher quality pet food, exemplified by brands offering plasma-enriched formulations to cater to discerning pet owners.

• Rise in Swine Production

The global demand for pork is steadily increasing, leading to a surge in swine production. This rise in production necessitates effective strategies to optimize growth and health in pigs. As a result, there's a rising need for feed additives such as porcine plasma, renowned for its abundance of vital nutrients and antibodies. These additives play a crucial role in promoting piglet health and optimizing growth rates, fulfilling the industry's quest for effective production solutions.

Opportunities

• Increased Focus on Animal Welfare

Increasing consumer awareness regarding animal welfare drives a discernible preference for feed additives that prioritize animal health. This trend reflects a growing societal emphasis on ethical treatment of animals in agricultural practices. Porcine plasma stands out as a natural and safe porcine blood plasma ingredient in this regard. For instance, its inclusion in piglet feed formulations supports optimal growth and health. It addresses consumer concerns about the well-being of animals raised for pork production while ensuring high-quality nutrition.

• High Nutritional Value Creates Demand

Porcine plasma offers a wealth of essential nutrients crucial for piglet growth and health. Packed with proteins, immunoglobulins, and growth factors, it optimizes development and supports immune function. For instance, the presence of antibodies aids in combating diseases such as porcine epidemic diarrhea virus (PEDV), ensuring healthier herds. This nutrient-rich composition makes porcine plasma a valuable component in piglet feed formulations.

Restraints/Challenges

• Regulatory Restrictions on Animal-Derived Feed

Stringent regulations on animal-derived feed additives, such as porcine plasma, hinder market expansion due to disease transmission and food safety concerns. Regulatory bodies enforce strict guidelines to safeguard animal and human health, potentially limiting the use of such products. Compliance with these regulations necessitates thorough safety protocols and may increase production costs, constraining market accessibility and growth potential.    

• Fluctuations in the Cost of Porcine Plasma

The porcine plasma feed market faces price volatility, influenced by shifts in demand, production hurdles, and trade dynamics. Fluctuations can disrupt affordability and profitability for feed producers, necessitating agile strategies to manage costs effectively. Such instability underscores the importance of diversified sourcing strategies and risk management practices to mitigate the impact on feed formulation economics.   

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays

Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions.

Apart from the standard report, we also offer in-depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.

Expected Impact of Economic Slowdown on the Pricing and Availability of Products

When economic activity slows, industries begin to suffer. The forecasted effects of the economic downturn on the pricing and accessibility of the products are taken into account in the market insight reports and intelligence services provided by DBMR. With this, our clients can typically keep one step ahead of their competitors, project their sales and revenue, and estimate their profit and loss expenditures.

Recent Developments

• In October 2022, Grifols inaugurated a new albumin purification and filling facility in Dublin, Ireland, enhancing its global production and supply capabilities. The strategic move bolsters Grifols' position in the biopharmaceutical industry, signaling its commitment to innovation and meeting the growing demand for plasma-derived therapies on a worldwide scale
• In September 2022, CSL Behring K.K. obtained manufacturing and marketing approval from Japan's Ministry of Health, Labour, and Welfare for Berinert S.C. Injection 2000. This lyophilized human C1-esterase inhibitor concentrate for subcutaneous injection offers a vital treatment option for preventing acute hereditary angioedema attacks, addressing significant medical needs, and improving patient outcomes
• In April 2022, Takeda Pharmaceutical Company Limited completed its acquisition of Shire Plc, significantly expanding its product portfolio and market presence in plasma-based therapeutics. This strategic acquisition reinforces Takeda's commitment to advancing healthcare through innovation and strengthens its position in the competitive plasma market, driving future growth and development opportunities

Porcine Plasma Feed Market Scope

The market is segmented on the basis of application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Application

• Swine Feed
• Pet Food
• Aquafeed
• Others

 End-User

• Farmers
• Farming Organizations
• Feed Additive Companies
• Users of Animal Feed for Pets

Porcine Plasma Feed Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided by country, application, and end-user as referenced above.

The countries covered in the market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.

Asia-Pacific is estimated to register significant growth in the market. The increasing demand for animal-based products, including porcine blood plasma feed, coupled with high slaughter rates of animals in various Asia-Pacific countries, drives this growth within the forecasted period.

North America is expected to dominate the market due to the need for antibiotic replacement in feed and a robust market for organic meat. This trend compels farmers to opt for natural ingredients, driving the region's leadership in the forecasted period.

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

竞争格局和猪血浆饲料市场份额分析

市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对市场的关注有关。

市场上的一些主要参与者包括：

• Apcproteins（美国）
• SARIA A/S GmbH & Co. KG（德国）
•  Sera-Scandia A/S（丹麦）
•  Lican Food（智利）
•  PURETEIN AGRI LLC.（美国）
•  Veos（比利时）
•  Kraeber & Co Gmbh（德国）
•  雷德利有限公司 (澳大利亚)
•  Allanasons Private Limited（印度）
•  落基山生物制品公司（美国）
• Lihme 蛋白质解决方案（丹麦）
•  Ekofood（美国）
• FeedWorks Pty. Ltd.（澳大利亚）
•  Darling Ingredients（美国）
• Nutreco (荷兰)
•  West Coast Reduction Ltd.（美国）
•  Valley Proteins, Inc.（美国）
•  FASA 集团（巴西）

SKU-56333